A clinical study showed that it is discrepancy for serum ceruloplasmin (CP) levels in PD patients, and that serum CP reduction is more easily to accelerate the progression of PD than that of serum CP normal patients 36 , which might be the same as the global Cp gene deficiency related parkinsonism symptoms in aceruloplasminemia patients and Cp -/- mice 37,38
For a broader look at peptide therapy economics, we maintain a separate complete 2026 guide to peptide therapy cost across all our protocols that covers GLP-1 medications, NAD+, and other peptide stacks beyond BPC-157
The dose is deliberately high compared to classical peptides (5-10 mg for GLP-1 analogues, 2-5 mg for short regeneratives) because documented GHK-Cu protocols use larger quantities in trichological and cutaneous research (1-3 mg per injection, concentrated topical applications)
Used thoughtfully and with realistic expectations, it is a reasonable ingredient for many people provided decisions are grounded in evidence rather than hype